The Kaplan–Meier plotter online database showed that high expression of MEOX2 was significantly correlated with better survival in breast cancer patients, and the same conclusion was obtained in ER-positive and HER2-negative subgroups. This evidence concerns the gene MEOX2 and breast carcinoma.